Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (138)

91

Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment

enthalten in: Cancers | 2021

von Thy, S. | Hommel, A. | Meneceur, S. | +4

92

Ovarian Cancer Treatments Strategy : Focus on PARP Inhibitors and Immune Check Point Inhibitors

enthalten in: Cancers | 2021

von Nero, C. | Ciccarone, F. | Pietragalla, A. | +6

93

Homologous Recombination Deficiency Testing for BRCA-Like Tumors : The Road to Clinical Validation

enthalten in: Cancers | 2021

von Ladan, M. | van Gent, D. | Jager, A.

94

Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine : An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation

enthalten in: Cancers | 2021

von Waissi, W. | Nicol, A. | Jung, M. | +4

95

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin

enthalten in: Cancers | 2021

von Fan, D. | Yang, H. | Mao, W. | +7

96

Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC

in: Cancers | 2021

von Kimberly M. Burcher | Andrew T. Faucheux | Jeffrey W. Lantz | +12

97

Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

in: Cancers | 2021

von Camilla Nero | Francesca Ciccarone | Antonella Pietragalla | +6

98

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin

in: Cancers | 2021

von Dengxuan Fan | Hailing Yang | Weiqun Mao | +7

99

High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients

in: Cancers | 2021

von Manuela Giansanti | Terry Karimi | Isabella Faraoni | +1

100

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

in: Cancers | 2021

von Clifford M. Csizmar | Antoine N. Saliba | Elizabeth M. Swisher | +1